| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |